News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major news released in the past hour; markets saw limited headline-driven movement.
  • Global equity and bond markets reported light trading volume and narrow price ranges.
  • No central bank statements or new economic data scheduled within the hour.
  • No significant geopolitical incidents or major corporate announcements reported.
  • Oil and commodity prices traded within tight ranges absent fresh supply or demand drivers.
  • Investors positioned cautiously ahead of upcoming economic releases and corporate earnings.

Latest Articles

Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting

Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting

Legend Biotech announced that updated long-term follow-up and real-world evidence from its CARVYKTI® (ciltacabtagene autoleucel) clinical trials, including CARTITUDE-2 Cohort A, will be presented at the 23rd International Myeloma Society Annual Meeting. These new data further support CARVYKTI's safety and efficacy in treating relapsed/refractory mu…

Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting

Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting

Rhythm Pharmaceuticals announced new data presentations at the European Society for Paediatric Endocrinology meeting highlighting real-world and Phase 3 clinical trial results for setmelanotide in treating pediatric acquired hypothalamic obesity. The data demonstrate significant and sustained BMI reductions and improvements across several cardiomet…

BWT Alpine Formula One Team and SEALSQ advance Formula One’s First Quantum Security Partnership with Hybrid Quantum-Classical Simulation

BWT Alpine Formula One Team and SEALSQ advance Formula One’s First Quantum Security Partnership with Hybrid Quantum-Classical Simulation

SEALSQ (NASDAQ: LAES) and BWT Alpine Formula One Team have advanced their collaboration by integrating ColibriTD's hybrid quantum-classical simulation technology to accelerate and improve fundamental physics problem-solving within Formula One engineering. This project aims to leverage quantum-powered computations alongside quantum-secure infrastruc…

Mobilicom to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15th

Mobilicom to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15th

Mobilicom Limited, a cybersecurity and communications solutions provider for drones and robotics, announced it will present its growth strategy and market opportunities at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026. The CEO will deliver a live presentation and hold investor meetings, highlighting the company'…

ATIF Holdings Limited Completes Acquisition of GoldCoin Labs, Expanding into Gold-Backed Digital Asset Sector

ATIF Holdings Limited Completes Acquisition of GoldCoin Labs, Expanding into Gold-Backed Digital Asset Sector

ATIF Holdings Limited, a Nasdaq-listed company, has completed its acquisition of GoldCoin Labs, a company developing gold-backed digital asset issuance infrastructure. This acquisition diversifies ATIF's digital asset portfolio by adding a tokenized gold platform, potentially enhancing revenue streams and positioning the company within the growing …

One and One Green Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

One and One Green Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

One and One Green Technologies, a Philippines-based recycler of non-ferrous metals and industrial materials, will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York City. The company aims to build direct relationships with US institutional investors focused on metals and cleantech sectors. One and One converts elect…

Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology

Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology

Adagene Inc. announced that Third Arc Bio selected the first lead candidate under their amended strategic collaboration focused on developing masked CD3 T cell engagers using Adagene's SAFEbody® technology. The partnership's scope has expanded to include Third Arc Bio sponsoring and funding clinical development, increasing potential payments to Ada…

Teads Expands Global CTV Offering with Whale TV Partnership

Teads Expands Global CTV Offering with Whale TV Partnership

Teads has extended its partnership with Whale TV globally, allowing advertisers worldwide to access Whale TV's HomeScreen and native connected TV inventory through Teads Ad Manager. This expansion broadens Teads' CTV footprint across major and emerging markets and supports unified campaign management across devices, leveraging Teads' AI and measure…

Commerce Announces Strategic Operating Plan to Accelerate Profitability and Free Cash Flow Generation

Commerce Announces Strategic Operating Plan to Accelerate Profitability and Free Cash Flow Generation

Commerce.com, Inc. revealed a strategic operating plan targeting annualized cost savings of $60-$80 million, aiming for non-GAAP operating margins of at least 20% by 2027, while maintaining key growth investments. The plan includes a board-approved $50 million share repurchase authorization over two years and updates 2026 guidance with increased op…